Aim: To evaluate the role of tobacco use in the development of psychosis in individuals at clinical high risk.
Method: The North American Prodrome Longitudinal Study is a 2-year multi-site prospective case control study of persons at clinical high risk that aims to better understand predictors and mechanisms for the development of psychosis. The cohort consisted of 764 clinical high risk and 279 healthy comparison subjects. Clinical assessments included tobacco and substance use and several risk factors associated with smoking in general population studies.
Results: Clinical high risk subjects were more likely to smoke cigarettes than unaffected subjects (light smoking odds ratio [OR] = 3.0, 95% confidence interval [CI] = 1.9-5; heavy smoking OR = 4.8, 95% CI = 1.7-13.7). In both groups, smoking was associated with mood, substance use, stress and perceived discrimination and in clinical high risk subjects with childhood emotional neglect and adaption to school. Clinical high risk subjects reported higher rates of several factors previously associated with smoking, including substance use, anxiety, trauma and perceived discrimination. After controlling for these potential factors, the relationship between clinical high risk state and smoking was no longer significant (light smoking OR = 0.9, 95% CI = 0.4-2.2; heavy smoking OR = 0.3, 95% CI = 0.05-2.3). Moreover, baseline smoking status (hazard ratio [HR] = 1.16, 95% CI = 0.82-1.65) and categorization as ever smoked (HR = 1.3, 95% CI = 0.8-2.1) did not predict time to conversion.
Conclusion: Persons at high risk for psychosis are more likely to smoke and have more factors associated with smoking than controls. Smoking status in clinical high risk subjects does not predict conversion. These findings do not support a causal relationship between smoking and psychosis.
Keywords: clinical high risk; psychosis; schizophrenia; substance use disorder; tobacco.
© 2018 John Wiley & Sons Australia, Ltd.
Addiction Vulnerability: Exploring Relationships Among Cigarette Smoking, Substance Misuse, and Early PsychosisV Clark et al. J Dual Diagn 14 (2), 78-88. PMID 29261427.Smoking status at service presentation appeared to function as a general proxy for addiction vulnerability among young help seekers and thereby as a potential marker for …
Does Tobacco Use Cause Psychosis? Systematic Review and Meta-AnalysisP Gurillo et al. Lancet Psychiatry 2 (8), 718-725. PMID 26249303. - ReviewNIHR Maudsley Biomedical Research Centre.
Evidence of a Causal Relationship Between Smoking Tobacco and Schizophrenia Spectrum DisordersJG Scott et al. Front Psychiatry 9, 607. PMID 30515111. - ReviewThere has been emerging evidence of an association between tobacco smoking and schizophrenia spectrum disorders (SSD). Two meta-analyses have reported that people who smo …
Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal StudyLJ Seidman et al. JAMA Psychiatry 73 (12), 1239-1248. PMID 27806157.Neurocognitive impairment, especially in attention and working memory abilities and declarative memory abilities, is a robust characteristic of CHR participants, especial …
Smoking and Schizophrenia in Population Cohorts of Swedish Women and Men: A Prospective Co-Relative Control StudyKS Kendler et al. Am J Psychiatry 172 (11), 1092-100. PMID 26046339.Smoking prospectively predicts risk for schizophrenia. This association does not arise from smoking onset during a schizophrenic prodrome and demonstrates a clear dose-re …